MedTrace Logo

Ustekinumab Real World Evidence Study

NCT07748338 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 601

Last updated 2026-08-05

No results posted yet for this study

Summary

The purpose of this study is to capture the real-world experience of CD patients treated with ustekinumab as part of their clinical care in a variety of care settings from large teaching/research centres to smaller district hospitals.

Conditions

Interventions

DRUG

Ustekinumab

Intravenous baseline, subcutaneous follow ups.

Sponsors & Collaborators

  • Liverpool University Hospitals NHS Foundation Trust

    collaborator OTHER_GOV

  • University Hospital Southampton NHS Foundation Trust

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-30
Primary Completion
2025-03-20
Completion
2025-03-20

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07748338 on ClinicalTrials.gov